The Ke Yuan lab at Boston Children's Hospital and Harvard Medical School will dissect the critical role of pericytes during angiogenesis and aim to understand abnormal vascular remodeling in pulmonary arterial hypertension (PAH) and other pulmonary vascular diseases. The ultimate goal is to identify potential therapeutic targets that could be exploited for the development of new drugs capable of preventing abnormal vessel remodeling and obliteration in PAH.
Congratulations to Timothy Klouda, Yuan Hao, Hyunbum Kim, Jiwon Kim on the new research paper published in Angiogenesis, entitled "Interferon‑alpha or ‑beta facilitates SARS‑CoV‑2 pulmonary vascular infection by inducing ACE2". These findings are relevant to clinical observations and in line with newly released NIH recommendations: https://lnkd.in/gYVMYBXm.
Please check out this article: https://lnkd.in/guvNnkg3 or as a PDF here https://lnkd.in/gRUFDBpy.
300 Longwood Ave, Boston, MA 02115